News Stocks Dishman Carbogen Amcis Subsidiary Receives GMP Compliance Certificate for Veenendaal FacilityDishman Carbogen Amcis Subsidiary Receives GMP Compliance Certificate for Veenendaal Facility
Dishman Carbogen Amcis Limited announced that its subsidiary Carbogen Amcis B.V. has received a GMP compliance certificate for its Veenendaal facility from the Health and Youth Care Inspectorate. This regulatory milestone validates the facility's adherence to pharmaceutical manufacturing quality standards and strengthens the company's European operations.
*this image is generated using AI for illustrative purposes only.
Dishman Carbogen Amcis Limited has announced that its subsidiary Carbogen Amcis B.V. has successfully obtained a Good Manufacturing Practice (GMP) compliance certificate for its Veenendaal facility from the Health and Youth Care Inspectorate.
Regulatory Milestone Achievement
The GMP compliance certificate represents a significant regulatory achievement for the company's European operations. This certification validates that the Veenendaal facility meets the stringent quality standards required for pharmaceutical manufacturing operations.
| Parameter: | Details |
|---|---|
| Facility Location: | Veenendaal |
| Certifying Authority: | Health and Youth Care Inspectorate |
| Certificate Type: | GMP Compliance |
| Subsidiary: | Carbogen Amcis B.V. |
About the Certification
GMP compliance certificates are essential regulatory approvals that ensure pharmaceutical manufacturing facilities adhere to quality standards and regulatory requirements. The certification from the Health and Youth Care Inspectorate enables the facility to maintain its operational status for pharmaceutical manufacturing activities.
This development strengthens Dishman Carbogen Amcis Limited's regulatory standing in the European market through its subsidiary operations.
18
